Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • The cost of caring for people with dementia is $157-215B a year and could double by 2040, a study from RAND Corp. estimates. The cost of dementia treatment is $109B - above the $102B spent on heart disease and the $77B on cancer - with the other dementia expenses used for long-term day-to-day care. Companies that develop drugs for Alzheimer's disease and other conditions include Pfizer (PFE), Eli Lilly (LLY), J&J (JNJ) and Merck (MRK). [View news story]
    Current drugs are ABSOLUTELY useless for people with dementia but can make life easier for the people caring for the dementing patient--mostly by immobilizing the patient through tranquilizers. None of the current drugs nor the current supported research thinking goes to root causes of Alzheimer's disease or the other dementing diseases. However, all these guilt drugs are great for big pharma's bottom line and for supporting professors and researchers and all the ancillary services of the pharma industry!
    Apr 4, 2013. 01:50 PM | Likes Like |Link to Comment
1 Comment